Mitsui Chemicals to Increase Production Capacity for TAFMER™ High-Performance Elastomers
Mitsui Chemicals, Inc. (TOKYO:4183)(President & CEO: Tsutomu Tannowa) today announced that Mitsui Elastomers Singapore Pte Ltd (MELS; Managing Director: Shinya Matsunaga), a wholly owned subsidiary based in Singapore, is set to raise its production capacity for TAFMER™ high-performance elastomers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180823005185/en/
TAFMER™ holds a world-leading market share as a resin modifier and soft molding material. Both flexible and lightweight, the elastomer series sees use in a wide range of applications, including automotive materials, packaging materials, solar battery encapsulants, engineering plastic modifiers and sports shoe midsoles.
Global economic growth is driving strong demand for TAFMER™, with automotive material applications in particular expected to see further demand growth going forward. This comes as automobile production numbers continue to rise and tightening environmental regulations spur needs for lightweighting.
Mitsui Chemicals has a long track record when it comes to supplying automotive material manufacturers around the world, focusing here on polypropylene (PP) compounds. To keep up its steady supply moving forward, the company plans to remove bottlenecks at existing TAFMER™ production facilities, allowing it to increase production capacity for the elastomer series.
Mitsui Chemicals and MELS are also considering additional increases to supply capacity for TAFMER™ as they look to grow their business here further. Through these plans, Mitsui Chemicals intends to be proactive in maintaining and strengthening its position as holding the top global share in this area.
[Outline of Expanded Production Capacity]
|1. Product||TAFMER™ high-performance elastomers|
|2. Factory location||Jurong Island, Singapore|
|3. Production Capacity||
200,000 tons/year (before expansion)
|4. Schedule||Completion in July 2020 (tentative)|
[Overview of MELS]
|1. Company Name||Mitsui Elastomers Singapore Pte Ltd|
|2. Head Office||3 HarbourFront Place #10-01 HarbourFront Tower 2 Singapore 099254, Singapore|
|3. Establishment||February 2001|
US$ 96.3 million
|5. Managing Director||Shinya Matsunaga|
|6. Business||Manufacture and sale of elastomers|
Mitsui Chemicals, Inc.
Takashi Kawamoto, +81-3-6253-2100
Corporate Communications Division
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
CA-ARENSIS/SCHNEIDER25.9.2018 15:02 | pressemeddelelse
Arensis and Schneider Electric Launch Smart Microgrid Partnership and Development of ENTRADE IO Blockchain Technology
RI-CLARKE-VALVE25.9.2018 15:02 | pressemeddelelse
Clarke Valve Closes $5.5 Million Venture Funding Round Led by OGCI Climate Investments
CA-ANALOGIX25.9.2018 15:02 | pressemeddelelse
Analogix Introduces Industry’s Lowest Power eDP TCON with In-Cell Touch for Latest Generation Notebooks
MA-TAKEDA-PHARMACEUTICAL25.9.2018 14:34 | pressemeddelelse
Takeda to Present Positive Data from ALUNBRIG® (brigatinib) ALTA-1L Trial Showing a Reduction in Risk of Disease Progression or Death of More Than 50 Percent Versus Crizotinib in First-Line Advanced ALK+ NSCLC
SOFTOMOTIVE25.9.2018 14:17 | pressemeddelelse
Softomotive and Enate Partner to Help Clients Orchestrate Workflows across Their RPA Ecosystem
CA-SCIENTIST.COM25.9.2018 14:08 | pressemeddelelse
Scientist.com Adds Experienced Drug Hunter Mark Herbert to Management Team
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum